Global Medical REIT Beheer
Beheer criteriumcontroles 3/4
De CEO Global Medical REIT is Jeff Busch, benoemd in Aug2015, heeft een ambtstermijn van 9.25 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 2.18M, bestaande uit 32.1% salaris en 67.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.065% van de aandelen van het bedrijf, ter waarde $ 391.07K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 8.7 jaar en 8.7 jaar.
Belangrijke informatie
Jeff Busch
Algemeen directeur
US$2.2m
Totale compensatie
| Percentage CEO-salaris | 32.1% |
| Dienstverband CEO | 9.3yrs |
| Eigendom CEO | 0.07% |
| Management gemiddelde ambtstermijn | 8.7yrs |
| Gemiddelde ambtstermijn bestuur | 8.7yrs |
Recente managementupdates
Recent updates
Global Medical REIT's Underwriting Is Demonstrated To Be Effective
Sep 24Global Medical REIT: Stability Across The Board, But More Is Needed To Be Bullish
Aug 11Global Medical: The Yield Is Not Too Good To Be True
Jun 26Global Medical: The 7.6% Preferred Yield Trumps The Common
May 23Global Medical REIT: Better Q1 Than Expected, But Still A Cautious Stance
May 09Global Medical REIT Offers A 9.3% Dividend Yield And 7.6% On The Preferreds
Mar 09Global Medical REIT: Nothing Promising After Q4 Results, Still A Hold
Feb 29Global Medical REIT: Patient In Stable Condition, Risk Priced In
Feb 02Global Medical REIT: A Hold Despite Improving Performance
Nov 21Global Medical: 7.7% Yielding Preferreds Are Expensive, A Look At Alternatives
Oct 16Global Medical REIT: Revisiting Dividend Assumption After Q2 Results
Sep 10Global Medical REIT: Higher For Longer Scenarios Will Stress The REIT
Aug 04Global Medical: The 9.5% Yield Appears Covered Despite Pressure From Interest Rates
Jun 29If EPS Growth Is Important To You, Global Medical REIT (NYSE:GMRE) Presents An Opportunity
Mar 13
Global Medical REIT: A Strong Buy At Attractive Valuations And 7.8% Dividend Yield
Jan 27Global Medical REIT: Brace For A Hawkish Fed
Dec 25Global Medical REIT GAAP EPS of $0.12
Nov 02Global Medical REIT: Passive Income Machine With Safe 10.8% Yield
Oct 21Global Medical REIT stock drops after BMO downgrades on elevated leverage
Oct 06Global Medical REIT Now Has A 9% Recession Resistant Yield
Sep 28Global Medical REIT declares $0.21 dividend
Sep 09Global Medical REIT: Significant Upside Potential, Along With A High Yielding Dividend
Aug 18Global Medical REIT: Market Dislocation From First To Worst, Opportunity Refreshed
Jun 29Global Medical REIT: Another Solid Quarter From This Growing Healthcare REIT
May 17Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$1m |
| Jun 30 2024 | n/a | n/a | -US$56k |
| Mar 31 2024 | n/a | n/a | US$15m |
| Dec 31 2023 | US$2m | US$700k | US$15m |
| Sep 30 2023 | n/a | n/a | US$16m |
| Jun 30 2023 | n/a | n/a | US$21m |
| Mar 31 2023 | n/a | n/a | US$11m |
| Dec 31 2022 | US$2m | US$650k | US$13m |
| Sep 30 2022 | n/a | n/a | US$17m |
| Jun 30 2022 | n/a | n/a | US$12m |
| Mar 31 2022 | n/a | n/a | US$13m |
| Dec 31 2021 | US$2m | US$600k | US$12m |
| Sep 30 2021 | n/a | n/a | US$9m |
| Jun 30 2021 | n/a | n/a | -US$5m |
| Mar 31 2021 | n/a | n/a | -US$7m |
| Dec 31 2020 | US$3m | US$298k | -US$8m |
| Sep 30 2020 | n/a | n/a | -US$8m |
| Jun 30 2020 | n/a | n/a | US$3m |
| Mar 31 2020 | n/a | n/a | US$4m |
| Dec 31 2019 | US$455k | n/a | US$3m |
| Sep 30 2019 | n/a | n/a | US$9m |
| Jun 30 2019 | n/a | n/a | US$9m |
| Mar 31 2019 | n/a | n/a | US$8m |
| Dec 31 2018 | US$396k | n/a | US$8m |
| Sep 30 2018 | n/a | n/a | US$440k |
| Jun 30 2018 | n/a | n/a | US$535k |
| Mar 31 2018 | n/a | n/a | -US$23k |
| Dec 31 2017 | US$673k | n/a | -US$2m |
Compensatie versus markt: De totale vergoeding ($USD 2.18M ) Jeff } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 3.17M ).
Compensatie versus inkomsten: De vergoeding van Jeff is gestegen terwijl het bedrijf verliesgevend is.
CEO
Jeff Busch (64 yo)
9.3yrs
Tenure
US$2,181,100
Compensatie
Mr. Jeffrey M. Busch, also known as Jeff, is Director of IMAC Holdings, Inc. from September 19, 2024. Mr. Busch is Chairman of the Board at Theralink Technologies, Inc. (formerly known as OncBioMune Pharma...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 9.3yrs | US$2.18m | 0.065% $ 391.1k | |
| CFO & Treasurer | 7.3yrs | US$1.41m | 0% $ 0 | |
| Chief Operating Officer | 8.7yrs | US$935.78k | 0.00075% $ 4.5k | |
| Chief Investment Officer | 9.3yrs | US$1.34m | 0% $ 0 | |
| General Counsel & Corporate Secretary | 7.5yrs | US$872.70k | 0% $ 0 | |
| Investor Relations Executive | no data | geen gegevens | geen gegevens |
8.7yrs
Gemiddelde duur
51yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van GMRE is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8.7 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 10.2yrs | US$2.18m | 0.065% $ 391.1k | |
| Independent Director | 9.3yrs | US$155.71k | 0.012% $ 70.4k | |
| Lead Independent Director | 9.3yrs | US$183.21k | 0.012% $ 69.5k | |
| Independent Director | 6.4yrs | US$177.77k | 0% $ 0 | |
| Independent Director | 6.5yrs | US$203.10k | 0% $ 0 | |
| Independent Director | 8.7yrs | US$153.48k | 0% $ 0 | |
| Director | 8.7yrs | geen gegevens | 0% $ 0 |
8.7yrs
Gemiddelde duur
65yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van GMRE wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.7 jaar).